布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的疗效观察

目的:探讨布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床疗效. 方法:选择2012 年7月-2014年12月收治的慢性阻塞性肺病急性加重期患者116例,按随机数字表法分为观察组和对照组各58例,对照组患者采用内科常规治疗方法,观察组患者在对照组基础上采用布地奈德联合特布他林雾化吸入治疗. 比较2组患者的治疗效果、血气分析指标、肺功能及呼吸困难评分情况. 结果:观察组患者治疗有效率为94. 83%,明显高于对照组的81. 03%,差异有统计学意义(P〈0. 05);与治疗前比较,观察组患者治疗后第一秒用力呼气量、第一秒用力呼气量/预计值、第一秒用力呼气量/用力肺活量、动脉氧...

Full description

Saved in:
Bibliographic Details
Published in中国医院用药评价与分析 Vol. 15; no. 8; pp. 1004 - 1006
Main Author 廖建丰
Format Journal Article
LanguageChinese
Published 福建省中医药大学第五临床医学院附属三明市第二医院呼吸内科,福建三明,366000 2015
Subjects
Online AccessGet full text
ISSN1672-2124
DOI10.14009/j.issn.1672-2124.2015.08.005

Cover

Abstract 目的:探讨布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床疗效. 方法:选择2012 年7月-2014年12月收治的慢性阻塞性肺病急性加重期患者116例,按随机数字表法分为观察组和对照组各58例,对照组患者采用内科常规治疗方法,观察组患者在对照组基础上采用布地奈德联合特布他林雾化吸入治疗. 比较2组患者的治疗效果、血气分析指标、肺功能及呼吸困难评分情况. 结果:观察组患者治疗有效率为94. 83%,明显高于对照组的81. 03%,差异有统计学意义(P〈0. 05);与治疗前比较,观察组患者治疗后第一秒用力呼气量、第一秒用力呼气量/预计值、第一秒用力呼气量/用力肺活量、动脉氧分压和动脉血二氧化碳分压以及呼吸困难评分明显改善,差异有统计学意义( P〈0. 05 );与对照组治疗后比较,观察组患者各指标改善程度明显,差异有统计学意义(P〈0. 05). 结论:布地奈德联合特布他林压缩雾化吸入可明显改善慢性阻塞性肺病急性加重期患者呼吸困难、缺氧等症状,改善肺功能,疗效较好,值得临床推广.
AbstractList 目的:探讨布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床疗效. 方法:选择2012 年7月-2014年12月收治的慢性阻塞性肺病急性加重期患者116例,按随机数字表法分为观察组和对照组各58例,对照组患者采用内科常规治疗方法,观察组患者在对照组基础上采用布地奈德联合特布他林雾化吸入治疗. 比较2组患者的治疗效果、血气分析指标、肺功能及呼吸困难评分情况. 结果:观察组患者治疗有效率为94. 83%,明显高于对照组的81. 03%,差异有统计学意义(P〈0. 05);与治疗前比较,观察组患者治疗后第一秒用力呼气量、第一秒用力呼气量/预计值、第一秒用力呼气量/用力肺活量、动脉氧分压和动脉血二氧化碳分压以及呼吸困难评分明显改善,差异有统计学意义( P〈0. 05 );与对照组治疗后比较,观察组患者各指标改善程度明显,差异有统计学意义(P〈0. 05). 结论:布地奈德联合特布他林压缩雾化吸入可明显改善慢性阻塞性肺病急性加重期患者呼吸困难、缺氧等症状,改善肺功能,疗效较好,值得临床推广.
R974; 目的:探讨布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床疗效. 方法:选择2012 年7月-2014年12月收治的慢性阻塞性肺病急性加重期患者116例,按随机数字表法分为观察组和对照组各58例,对照组患者采用内科常规治疗方法,观察组患者在对照组基础上采用布地奈德联合特布他林雾化吸入治疗. 比较2组患者的治疗效果、血气分析指标、肺功能及呼吸困难评分情况. 结果:观察组患者治疗有效率为94. 83%,明显高于对照组的81. 03%,差异有统计学意义(P<0. 05);与治疗前比较,观察组患者治疗后第一秒用力呼气量、第一秒用力呼气量/预计值、第一秒用力呼气量/用力肺活量、动脉氧分压和动脉血二氧化碳分压以及呼吸困难评分明显改善,差异有统计学意义( P<0. 05 );与对照组治疗后比较,观察组患者各指标改善程度明显,差异有统计学意义(P<0. 05). 结论:布地奈德联合特布他林压缩雾化吸入可明显改善慢性阻塞性肺病急性加重期患者呼吸困难、缺氧等症状,改善肺功能,疗效较好,值得临床推广.
Abstract_FL OBJECTIVE:To investigate the clinical efficacy of budesonide combined with terbutaline in compressing atomized inhalation in treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD). METHODS:116 cases with AECOPD from Jul. 2012 to Dec. 2014 were divided into observation group and control group according to random number table, with 58 cases in each group. The control group received conventional treatment of internal medicine, and based on the control group, the observation group additionally received budesonide combined with terbutaline in compressing atomized inhalation. The therapeutic efficacy, blood gas analysis index, pulmonary function and dyspnea score before and after treatment between two groups were compared. RESULTS: The effective rate of observation treatment group was 94. 83%, which was significantly higher than that of the control group 81. 03%, the difference was statistically significant (P<0. 05). FEV1, FEV1/predicated value, FEV1/FVC, PAO2, PACO2 and dyspnea score in the observation group after treatment improved more obviously than before treatment, and compared with the control group after treatment, the observation group improved the indexes more obvious, the difference was statistically significant ( P < 0. 05 ). CONCLUSIONS:Budesonide combined with terbutaline in compressing atomized inhalation in treatment of AECOPD can significantly improve symptoms of dyspnea, relieve the symptoms of hypoxia, improve pulmonary function, with a satisfactory clinical efficacy. It is worthy of clinical application.
Author 廖建丰
AuthorAffiliation 福建省中医药大学第五临床医学院附属三明市第二医院呼吸内科,福建三明366000
AuthorAffiliation_xml – name: 福建省中医药大学第五临床医学院附属三明市第二医院呼吸内科,福建三明,366000
Author_FL LIAO Jianfeng
Author_FL_xml – sequence: 1
  fullname: LIAO Jianfeng
Author_xml – sequence: 1
  fullname: 廖建丰
BookMark eNo9kE1LAlEUhu_CIDP_RNAup_sx9864DOkLhBa1l5lxxkZsNIcoW5kl2ScuaowSrUCkVdEmy_DXdGf0X3TF6GzOOQ_veQ-8MyDk5B0TgHkEJSRDGF_MSrbrOhJiCo5hhGUJQ0QlqEoQ0hAI__NpEHVdW4eYKhBjIodBjveOefONd2p88DE8uuH1WnD2KeBP3_NbDX59EXy_jB4G_NLj9R6vdvz3fuA1_OqzX-6O7vr8qSWGYeUr8AZBo-qXO2Ll54-j0yu_2Q7uT8bi29qwW-Gv7VkwZWk514z-9QjYXFneSqzFkhur64mlZMxgMo0xgjQ1rRJNZwo0LIJNBhEmhkJUyiymI2wiOa2QuE4MRnSWpsiAFlMFNEyNkghYmLjua46lOZlUNr9XdMS_1GGmJKqQLVkH44CgKuIR8rmJ3NjOO5ldWxwUivaOViylGFNUiiBE5BcpLZHS
ClassificationCodes R974
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.14009/j.issn.1672-2124.2015.08.005
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Investigation of Efficacy of Budesonide Combined with Terbutaline in Compressing Atomized Inhalation in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
DocumentTitle_FL Investigation of Efficacy of Budesonide Combined with Terbutaline in Compressing Atomized Inhalation in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
EndPage 1006
ExternalDocumentID zgyyyypjyfx201508005
667851001
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
ABDBF
ACUHS
EOJEC
OBODZ
PSX
TCJ
TUS
ID FETCH-LOGICAL-c645-631a8d83ab670cf32e60123c73856f6b12e14d739b3c63b6d51c0f6814dcea53
ISSN 1672-2124
IngestDate Thu May 29 04:11:26 EDT 2025
Wed Feb 14 10:21:21 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 8
Keywords 雾化吸入
Terbutaline
Budesonide
布地奈德
慢性阻塞性肺病急性加重期
Clinical efficacy
临床疗效
Atomization inhalation
Acute exacerbation of chronic obstructive pulmonary disease
特布他林
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c645-631a8d83ab670cf32e60123c73856f6b12e14d739b3c63b6d51c0f6814dcea53
Notes LIAO Jianfeng (Dept. of Respiration Medicine, Sanming Municipal Affiliated Second Hospital of Fujian Traditional Chinese Medicine University of the Fifth Clinical ~edical College, Fujian Sanming Y&O00, China)
Budesonide;Terbutaline;Atomization inhalation;Acute exacerbation of chronic obstructive pulmonary disease;Clinical efficacy
11-4975/R
OBJECTIVE:To investigate the clinical efficacy of budesonide combined with terbutaline in compressing atomized inhalation in treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD). METHODS:116 cases with AECOPD from Jul. 2012 to Dec. 2014 were divided into observation group and control group according to random number table, with 58 cases in each group. The control group received conventional treatment of internal medicine, and based on the control group, the observation group additionally received budesonide combined with terbutaline in compressing atomized inhalation. The therapeutic efficacy, blood gas analysis index, pulmonary function and dyspne
PageCount 3
ParticipantIDs wanfang_journals_zgyyyypjyfx201508005
chongqing_primary_667851001
PublicationCentury 2000
PublicationDate 2015
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – year: 2015
  text: 2015
PublicationDecade 2010
PublicationTitle 中国医院用药评价与分析
PublicationTitleAlternate Evaluation and Analysis of Drug-use in Hospitals of China
PublicationTitle_FL Evaluation and Analysis of Drug-Use in Hospitals of China
PublicationYear 2015
Publisher 福建省中医药大学第五临床医学院附属三明市第二医院呼吸内科,福建三明,366000
Publisher_xml – name: 福建省中医药大学第五临床医学院附属三明市第二医院呼吸内科,福建三明,366000
SSID ssib025702234
ssib017477209
ssib001103637
ssib051368574
ssib000405437
ssib001215202
ssib036441963
ssib006563103
ssib057928707
Score 2.0073237
Snippet 目的:探讨布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床疗效. 方法:选择2012 年7月-2014年12月收治的慢性阻塞性肺病急性加重期患者116例,按随机数字表法分为观察组和对照组各58例,对照组患者采用内科常规治疗方法,观察组患者在对照组基础上采用布地奈德联合特布他林雾化吸入治疗....
R974; 目的:探讨布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床疗效. 方法:选择2012...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 1004
SubjectTerms 临床疗效
布地奈德
慢性阻塞性肺病急性加重期
特布他林
雾化吸入
Title 布地奈德联合特布他林压缩雾化吸入治疗慢性阻塞性肺疾病急性加重期的疗效观察
URI http://lib.cqvip.com/qk/86765X/201508/667851001.html
https://d.wanfangdata.com.cn/periodical/zgyyyypjyfx201508005
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9RAFJ8AJsaL0agRUcPBORb7NdOZY7vbDTHRi5DgadN2W4gxCyokwgnRjetnOOhilICaEOJJ40UUw19jd-G_8L3Z0i0JIeoemvl4H_PetDO_6XbeEHKlFlhQJQNNWLym2TKxtYDLRDMArRt2zQlNG_c7X7_BR8ftaxNsoq-_XPhqaW42HIkWDt1X8j-9CmXQr7hL9h96NhcKBZCG_oUr9DBc_6qPqc-oJ6iwMCFL1NMx4TIqhKryqedQHwgMKm1Fo6sqhwpJPVlgt6nnUcmpz6n0qXSwSvhUeEjslagLxJJKD2ViVUkRK4Ge0iWUXmD3TBQFXECAcriqMlVCp66j5AhFA-UGqutVQWOA3c3YUZeDQgTbp2EFYlDqUldHgQJoyqrx0LCK4nKpsA80Q3bdIpAXtKD2ChAX0bnyAxCUlWlgbDkzFlsLzZbKEAed6SpRoBSEoMyKUqfciD5XckTXV5DIHZv_OaR872VeRCY3Y_L04ouY7ibUbNbgjqkBBrALD4wozAoYla-AMCDLD529YDyVavpCqSO5VPwAkalAszrrTdv5x5Qc8AbDUFr95JjpcI7neJRvjRdAO8DyAggFwGfxYh6PNi4EgQOEj4fP7edhyQorsF6QNzz2EDBlPopbiKhlL4gbM_BMAxX-PLfgOKH79l09yjoMcDI1XZ-8C7BN7aKrJ0F9sgD4xk6Rk9lKbdjtPnanSd_C1BlyJ916lK5-TTea6c733Yev0-Vm5-kPKPy93WqvraSvnnd-fd57v5O-aKXLW2ljo_1tu9NaaTc-tRc3995upx_XILG79LPT2umsNNqLG5BNn33Ye_KyvbreefcYid80dzeX0i_rZ8nNij9WGtWyA0u0iNtMA7cFoiasIOSOHiWWGXNcsUQYMIonPDTMGIc_S4ZWxK2Q15gR6QkXUBjFAbPOkYH6dD0-T4atgMXCjGJYzZt2IgKJh8oxIQVjQVQzzEEylPupOtMNS1PN74NBQjPPVbPB6n51YXIefjO355MH6G9cJ7ILR0oZIieQsvu68SIZmL03F18CAD4bXlb31x8wZ7OV
linkProvider CAB International
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%B8%83%E5%9C%B0%E5%A5%88%E5%BE%B7%E8%81%94%E5%90%88%E7%89%B9%E5%B8%83%E4%BB%96%E6%9E%97%E5%8E%8B%E7%BC%A9%E9%9B%BE%E5%8C%96%E5%90%B8%E5%85%A5%E6%B2%BB%E7%96%97%E6%85%A2%E6%80%A7%E9%98%BB%E5%A1%9E%E6%80%A7%E8%82%BA%E7%96%BE%E7%97%85%E6%80%A5%E6%80%A7%E5%8A%A0%E9%87%8D%E6%9C%9F%E7%9A%84%E7%96%97%E6%95%88%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E9%99%A2%E7%94%A8%E8%8D%AF%E8%AF%84%E4%BB%B7%E4%B8%8E%E5%88%86%E6%9E%90&rft.au=%E5%BB%96%E5%BB%BA%E4%B8%B0&rft.date=2015&rft.issn=1672-2124&rft.issue=8&rft.spage=1004&rft.epage=1006&rft_id=info:doi/10.14009%2Fj.issn.1672-2124.2015.08.005&rft.externalDocID=667851001
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86765X%2F86765X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyyyypjyfx%2Fzgyyyypjyfx.jpg